Power of plasma N-terminal proatrial natriuretic factor to determine haemodynamics in patients with cardiac disease: relation to serum creatinine

被引:5
作者
Dahle, MG
Simonsen, S
Hall, C
Kjekshus, JK
机构
[1] Univ Hosp Oslo, Rikshosp, Dept Med B, Oslo, Norway
[2] Univ Hosp Oslo, Rikshosp, Inst Surg Res, Oslo, Norway
关键词
atrial natriuretic factor; cardiac output; cardiovascular diseases; central venous pressure; creatinine; heart failure congestive; heart atrium; kidney; pulmonary artery; pulmonary wedge pressure;
D O I
10.1080/00365519850186373
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective. The aim was to examine the usefulness of plasma N-terminal proatrial natriuretic factor (N-terminal proANP) as a non-invasive marker of cardiac pressure in patients with normal to mildly elevated serum creatinine. Methods: Blood samples were drawn at rest from 100 patients with cardiac disease undergoing diagnostic cardiac catheterization. Results: Using multivariate analysis, N-terminal proANP was independently related to mean pulmonary capillary wedge pressure (PCWP), mean right atrial pressure, serum creatinine (s-creatinine) and cardiac index. These indices accounted for about 50% of the variation in N-terminal proANP All patients with N-terminal proANP <1000 pmol/l had normal PCWP (<13 mmHg). Areas under the receiver-operating characteristic (ROC) curves for N-terminal proANP for the detection of PCWP greater than or equal to 13, greater than or equal to 18 and greater than or equal to 24 mmHg were 0.903, 0.870 and 0.876, respectively. Conclusion: These results suggest that analysis of plasma N-terminal proANP is a simple and powerful method for assessing cardiac pressure in patients with heart disease and normal and mildly elevated s-creatinine (<165 mu mol/l). The value of N-terminal proANP cannot, however, indiscriminately be used to assess cardiac haemodynamics. N-terminal proANP measurement is a useful screening parameter for identifying patients with normal cardiac pressures.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 36 条
[1]  
[Anonymous], 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin, 10.1056/NEJM199209033271003]
[2]  
Armitage P, 1987, Statistical methods in medical research, V2nd
[3]  
BONARJEE VVS, 1995, BRIT HEART J, V73, P511
[4]   IMMUNOREACTIVE N-TERMINAL PRO-ATRIAL NATRIURETIC PEPTIDE IN HUMAN-PLASMA - PLASMA-LEVELS AND COMPARISONS WITH ALPHA-HUMAN ATRIAL NATRIURETIC PEPTIDE IN NORMAL SUBJECTS, PATIENTS WITH ESSENTIAL-HYPERTENSION, CARDIAC TRANSPLANT AND CHRONIC RENAL-FAILUR [J].
BUCKLEY, MG ;
SAGNELLA, GA ;
MARKANDU, ND ;
SINGER, DRJ ;
MACGREGOR, GA .
CLINICAL SCIENCE, 1989, 77 (05) :573-579
[5]  
CHOY AMJ, 1994, BRIT HEART J, V72, P16
[6]   ATRIAL-NATRIURETIC-FACTOR IN NORMAL SUBJECTS AND HEART-FAILURE PATIENTS - PLASMA-LEVELS AND RENAL, HORMONAL, AND HEMODYNAMIC-RESPONSES TO PEPTIDE INFUSION [J].
CODY, RJ ;
ATLAS, SA ;
LARAGH, JH ;
KUBO, SH ;
COVIT, AB ;
RYMAN, KS ;
SHAKNOVICH, A ;
PONDOLFINO, K ;
CLARK, M ;
CAMARGO, MJF ;
SCARBOROUGH, RM ;
LEWICKI, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1362-1374
[7]   Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].
Cowie, MR ;
Struthers, AD ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
PooleWilson, PA ;
Sutton, GC .
LANCET, 1997, 350 (9088) :1349-1353
[8]   Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction [J].
Davidson, NC ;
Naas, AA ;
Hanson, JK ;
Kennedy, NSJ ;
Coutie, WJ ;
Struthers, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (10) :828-831
[9]  
Dickstein K, 1997, J Card Fail, V3, P83, DOI 10.1016/S1071-9164(97)90039-7
[10]   ATRIAL STRETCH, NOT PRESSURE, IS THE PRINCIPAL DETERMINANT CONTROLLING THE ACUTE RELEASE OF ATRIAL NATRIURETIC FACTOR [J].
EDWARDS, BS ;
ZIMMERMAN, RS ;
SCHWAB, TR ;
HEUBLEIN, DM ;
BURNETT, JC .
CIRCULATION RESEARCH, 1988, 62 (02) :191-195